Item(by='JPLeRouzic', descendants=None, kids=[25796717], score=None, time=1610740342, title=None, item_type='comment', url=None, parent=25794705, text='A company named Neuraltus Pharmaceuticals created a drug named NP001. NP001, a pH-adjusted IV formulation of purified sodium chlorite, is a novel molecule that regulates inflammation in vitro and in vivo.<p>It was used in a phase II clinical trial for ALS, and a subset of patients did not have any progression during the 6 month trial [0]. Something highly improbable.<p>Unfortunately this was not confirmed in a following phase III trial.<p>[0] <a href="https:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;pmc&#x2F;articles&#x2F;PMC4396529&#x2F;" rel="nofollow">https:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;pmc&#x2F;articles&#x2F;PMC4396529&#x2F;</a>')